首页> 外文期刊>Sleep & breathing =: Schlaf & Atmung >Review of oral appliances for treatment of sleep-disordered breathing.
【24h】

Review of oral appliances for treatment of sleep-disordered breathing.

机译:口腔矫治器治疗睡眠呼吸障碍的综述。

获取原文
获取原文并翻译 | 示例
       

摘要

Between 1982 and 2006, there were 89 distinct publications dealing with oral appliance therapy involving a total of 3,027 patients, which reported results of sleep studies performed with and without the appliance. These studies, which constitute a very heterogeneous group in terms of methodology and patient population, are reviewed and the results summarized. This review focused on the following outcomes: sleep apnea (i.e. reduction in the apnea/hypopnea index or respiratory disturbance index), ability of oral appliances to reduce snoring, effect of oral appliances on daytime function, comparison of oral appliances with other treatments (continuous positive airway pressure and surgery), side effects, dental changes (overbite and overjet), and long-term compliance. We found that the success rate, defined as the ability of the oral appliances to reduce apnea/hypopnea index to less than 10, is 54%. The response rate, defined as at least 50% reduction in the initial apnea/hypopnea index (although it still remained above 10), is 21%. When only the results of randomized, crossover, placebo-controlled studies are considered, the success and response rates are 50% and 14%, respectively. Snoring was reduced by 45%. In the studies comparing oral appliances to continuous positive airway pressure (CPAP) or to uvulopalatopharyngoplasty (UPPP), an appliance reduced initial AHI by 42%, CPAP reduced it by 75%, and UPPP by 30%. The majority of patients prefer using oral appliance than CPAP. Use of oral appliances improves daytime function somewhat; the Epworth sleepiness score (ESS) dropped from 11.2 to 7.8 in 854 patients. A summary of the follow-up compliance data shows that at 30 months, 56-68% of patients continue to use oral appliance. Side effects are relatively minor but frequent. The most common ones are excessive salivation and teeth discomfort. Efficacy and side effects depend on the type of appliance, degree of protrusion, vertical opening, and other settings. We conclude that oral appliances, although not as effective as CPAP in reducing sleep apnea, snoring, and improving daytime function, have a definite role in the treatment of snoring and sleep apnea.
机译:在1982年至2006年之间,有89种不同的出版物涉及口腔矫治器治疗,涉及总共3,027名患者,报告了使用和不使用矫治器进行睡眠研究的结果。这些研究在方法论和患者人群方面构成了一个非常不同的群体,我们对其进行了综述并总结了结果。这项审查的重点是以下结果:睡眠呼吸暂停(即呼吸暂停/呼吸不足指数或呼吸障碍指数的降低),口服器具减少打的能力,口服器具对白天功能的影响,口服器具与其他治疗方法的比较(连续气道正压和手术),副作用,牙齿变化(咬合和喷射过多)以及长期依从性。我们发现,成功率(定义为口腔矫治器将呼吸暂停/呼吸不足指数降至10以下的能力)为54%。响应率定义为初始呼吸暂停/呼吸不足指数降低至少50%(尽管仍保持在10以上),为21%。仅考虑随机,交叉,安慰剂对照研究的结果时,成功率和响应率分别为50%和14%。打nor减少了45%。在将口腔矫治器与持续气道正压通气(CPAP)或肺上睑咽喉成形术(UPPP)进行比较的研究中,矫治器将初始AHI降低了42%,CPAP降低了其初始AHI的75%,UPPP降低了30%。大多数患者比CPAP更喜欢使用口腔矫治器。使用口腔用具可以改善白天的功能; 854例患者的Epworth嗜睡分数(ESS)从11.2降至7.8。随访依从性数据摘要显示,在30个月时,有56-68%的患者继续使用口腔矫治器。副作用相对较小,但很常见。最常见的是流涎过多和牙齿不适。功效和副作用取决于设备的类型,突出程度,垂直开口和其他设置。我们得出的结论是,尽管口服矫治器在减轻睡眠呼吸暂停,打呼,和改善白天功能方面不如CPAP有效,但在治疗打nor和睡眠呼吸暂停方面具有明确的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号